GENERIC NAME OF THE MEDICINAL PRODUCT:
2. Methylphenidate Hydrochloride Tablets USP 5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each uncoated tablet contains:
Methylphenidate
Hydrochloride IP……………………10mg
Excipients………………………………..q.s
Color: Ponceau 2R
2. Methylphenidate Hydrochloride Tablets USP 5mg
Each uncoated tablet contains:
Methylphenidate
Hydrochloride IP……………………5mg
Excipients………………………………..q.s
Color: Ponceau 4R
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE X PRESCRIPTION DRUG-WARNING: TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.
STORAGE & DOSAGE:
DOSAGE: As directed by the Psychiatrists.
Methylphenidate Hydrochloride Tablets USP 10mg Technical Specification:
| Product Name: | Methylphenidate Hydrochloride Tablets USP |
| Brand Name: | Generic |
| Strength: | (10mg), (5mg) |
| Dosage Form: | Tablets (uncoated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Central Nervous System Stimulants. |
| Indication: | Methylphenidate is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy. |
| Storage: | Store in a dry place, protected from light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
1. Methylphenidate Hydrochloride Tablets USP 10mg
2. Methylphenidate Hydrochloride Tablets USP 5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
1. Methylphenidate Hydrochloride Tablets USP 10mg
Each uncoated tablet contains:
Methylphenidate
Hydrochloride IP……………………10mg
Excipients………………………………..q.s
Color: Ponceau 2R
2. Methylphenidate Hydrochloride Tablets USP 5mg
Each uncoated tablet contains:
Methylphenidate
Hydrochloride IP……………………5mg
Excipients………………………………..q.s
Color: Ponceau 4R
THERAPEUTIC INDICATIONS:
Methylphenidate is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE X PORESCRIPTION DRUG-WARNING: TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.
STORAGE & DOSAGE:
STORAGE: Store in a dry place, protected from light & moisture.
DOSAGE: As directed by the Psychiatrists.
